• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例生化表现类似于神经型的非神经型戈谢病。

A case of nonneurologic Gaucher's disease that biochemically resembles the neurologic types.

作者信息

Glew R H, Gopalan V, Hubbell C A, Beutler E, Geil J D, Lee R E

机构信息

Department of Biochemistry, School of Medicine, University of New Mexico, Albuquerque 87131.

出版信息

J Neuropathol Exp Neurol. 1991 Mar;50(2):108-17. doi: 10.1097/00005072-199103000-00002.

DOI:10.1097/00005072-199103000-00002
PMID:1672707
Abstract

Systemic findings such as hepatosplenomegaly and typical Gaucher storage cells in a bone marrow aspirate led to the clinical diagnosis of Gaucher's disease in the seven-year old patient described in this report. On the basis of the lack of neurologic involvement the child was classified as having the Type 1, nonneurologic form of Gaucher's disease. After splenectomy glucocerebrosidase was extracted from her spleen for biochemical analysis. As expected, a marked deficiency of glucocerebrosidase activity was evident in the splenic extract, however her enzyme displayed anomalous behavior compared to other identical splenic preparations from documented Type 1 Gaucher's disease patients in that it failed to reconstitute with the acidic lipid phosphatidylserine. Using the polymerase chain reaction (PCR)-based color complementation assay and restriction endonuclease analysis, we compared the mutation genotype of this child with that of five other classical Type 1 patients. This analysis revealed that our patient alone was homoallelic for a T----C transition at position 1448 in the glucocerebrosidase cDNA that results in a 444Leu----Pro substitution in the glucocerebrosidase protein. The latter mutation genotype is normally associated with the neurologic phenotype, namely, the Types 2 and 3 forms of the disease. The relevance of the nature of polarity in clinical and biochemical analyses is discussed with regard to the phenotypic classification and the future clinical course of disease in the child.

摘要

本报告中描述的一名7岁患者出现了全身性表现,如肝脾肿大,骨髓穿刺中发现典型的戈谢贮积细胞,从而临床诊断为戈谢病。基于无神经系统受累,该患儿被归类为患有1型非神经型戈谢病。脾切除术后,从她的脾脏中提取了葡萄糖脑苷脂酶进行生化分析。正如预期的那样,脾脏提取物中明显缺乏葡萄糖脑苷脂酶活性,然而,与来自已确诊的1型戈谢病患者的其他相同脾脏制剂相比,她的酶表现出异常行为,即它不能与酸性脂质磷脂酰丝氨酸重构。使用基于聚合酶链反应(PCR)的颜色互补分析和限制性内切酶分析,我们将该患儿的突变基因型与其他五名经典1型患者的突变基因型进行了比较。分析显示,只有我们的患者在葡萄糖脑苷脂酶cDNA的第1448位存在T----C转换的纯合等位基因,这导致葡萄糖脑苷脂酶蛋白中444Leu----Pro替代。后一种突变基因型通常与神经表型相关,即2型和3型疾病。关于极性性质在临床和生化分析中的相关性,针对该患儿的表型分类和未来疾病临床进程进行了讨论。

相似文献

1
A case of nonneurologic Gaucher's disease that biochemically resembles the neurologic types.一例生化表现类似于神经型的非神经型戈谢病。
J Neuropathol Exp Neurol. 1991 Mar;50(2):108-17. doi: 10.1097/00005072-199103000-00002.
2
Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.戈谢病神经型和非神经型的酶学鉴别
J Neuropathol Exp Neurol. 1982 Nov;41(6):630-41. doi: 10.1097/00005072-198211000-00006.
3
Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.不同N-酰基的N-酰基磷脂酰乙醇胺作为不同类型戈谢病中葡萄糖脑苷脂酶激活剂的比较。
Arch Biochem Biophys. 1985 Nov 15;243(1):28-34. doi: 10.1016/0003-9861(85)90770-2.
4
A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.神经元型戈谢病中人类葡萄糖脑苷脂酶基因的突变。
N Engl J Med. 1987 Mar 5;316(10):570-5. doi: 10.1056/NEJM198703053161002.
5
Activators of spleen glucocerebrosidase from controls and patients with various forms of Gaucher's disease.来自对照人群及各种类型戈谢病患者的脾脏葡萄糖脑苷脂酶激活剂。
J Biol Chem. 1984 Feb 10;259(3):1714-9.
6
Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.1型和2型戈谢病中磷脂激活的β-葡萄糖苷酶的蔗糖梯度分析
Arch Biochem Biophys. 1985 Apr;238(1):344-52. doi: 10.1016/0003-9861(85)90173-0.
7
Gaucher's disease in Lithuania: its diagnosis and treatment.在立陶宛的戈谢病:诊断和治疗。
Medicina (Kaunas). 2011;47(7):405-11.
8
Coincidence of Gaucher's disease due to a private mutation and Ph' positive chronic myeloid leukemia.
Am J Hematol. 1998 Sep;59(1):87-90. doi: 10.1002/(sici)1096-8652(199809)59:1<87::aid-ajh17>3.0.co;2-z.
9
Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.2型戈谢病患者的基因型异质性和表型变异。
Pediatr Res. 1998 May;43(5):571-8. doi: 10.1203/00006450-199805000-00003.
10
Detection of the 1226 (Jewish) mutation for Gaucher's disease by color PCR. A means for studying the gene frequency of the disorder.
Am J Clin Pathol. 1990 Jun;93(6):788-91. doi: 10.1093/ajcp/93.6.788.

引用本文的文献

1
Phenotypic and genotypic heterogeneity in gaucher disease: Implications for genetic counseling.戈谢病的表型和基因型异质性:对遗传咨询的意义。
J Genet Couns. 1994 Mar;3(1):13-22. doi: 10.1007/BF01414603.
2
Role of pH in determining the cell-type-specific residual activity of glucocerebrosidase in type 1 Gaucher disease.pH在决定1型戈谢病中葡萄糖脑苷脂酶细胞类型特异性残余活性方面的作用。
J Clin Invest. 1993 Mar;91(3):1167-75. doi: 10.1172/JCI116276.